XON News and Press, Intrexon Corporation

Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares PR Newswire GERMANTOWN, Md. , Jan. 26, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) announced today the closing of its previously ann...

Pioneer Natural Resources (PXD) is well positioned to benefit from the recovery of the global economy because the demand for oil and natural gas will rise with the resumption of industrial operations. Also, the company’s progress on strategic acquisitions and in providing unique scale ...

Precigen to Present at the 39th Annual J.P. Morgan Healthcare Conference - Management will also participate in a panel discussion at the H.C. Wainwright BioConnect 2021 Conference - PR Newswire GERMANTOWN, Md. , Jan. 6, 2021 /PRNewswire/ -- Precigen, In...

Precigen Reports Third Quarter 2020 and Year-to-Date Financial Results - Company to provide comprehensive clinical pipeline and data updates in early December - - Continues to advance healthcare portfolio and improve fiscal performance by executing operational efficiencies -...

Precigen to Announce Third Quarter 2020 Financial Results on November 9th: Will host Pipeline and Data Update Call in Early December PR Newswire GERMANTOWN, Md., Nov. 2, 2020 GERMANTOWN, Md. , Nov. 2, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN...

GERMANTOWN, Md. , Feb. 3, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the closing of its previously announced sale of a num...

The following slide deck was published by Intrexon Corporation in conjunction with this Read more ...

The following slide deck was published by Intrexon Corporation in conjunction with this Read more ...

GERMANTOWN, Md. , Jan. 9, 2020 /PRNewswire/ --  Triple-Gene LLC , a clinical stage cardiovascular gene therapy company, today announced that Thomas D. Reed , PhD, Co-Founder, will present at the Biotech Showcase on January 15 th , 2020 at 11:30AM PT at the Hilton San Francisco U...

GERMANTOWN, Md. , Jan. 6, 2020 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced that the US Food and Drug Administration (FDA) has granted orphan drug des...